NEWARK, Del, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The Hyaluronic Viscosupplementation Market is experiencing a substantial surge in demand as it emerges as a leading solution for individuals seeking relief from joint pain and mobility issues. Hyaluronic viscosupplementation involves injecting hyaluronic acid-based formulations into joints affected by osteoarthritis, providing lubrication and cushioning to reduce pain and improve joint function.
With a growing aging population and increased sports-related injuries, joint disorders have become a prevalent health concern worldwide. As a minimally invasive and effective treatment option, hyaluronic viscosupplementation is gaining popularity among patients and healthcare providers alike.
The global market for hyaluronic viscosupplementation is expected to grow at a significant rate in the coming years, driven by several factors including increasing rising knee injuries around the globe and increasing cases of falls. The global market currently stands at US$ 2.3 Billion in 2022, and it is further projected to expand at a CAGR of 5.2% over the forecast period (2023-2033).
The World Health Organization highlights osteoarthritis (OA) as a significant contributor to functional disability in older adults, affecting 9.6% of men and 18% of women aged over 60 years.
Viscosupplements, containing hyaluronic acid, are being used to improve viscoelasticity, reduce symptoms, and enhance joint functionality. These molecules are incorporated with anti-inflammatory drugs to improve short-term pain relief and enhance the bioactive principle at the injured cartilage site. Combining viscosupplements with regenerative therapies is promising for stimulating intrinsic cartilage repair and regeneration. The cost of treatment is minimum and affordable for all sections of patients.
In general, the hyaluronic viscosupplementation market is likely to expand more in the coming years. This market provides people with a cheaper and more convenient way to improve their joint condition.
Stay Ahead Of The Curve in the Rapidly Growing Hyaluronic Viscosupplementation Market with Our Comprehensive Sample Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-17713
Key Takeaways from Hyaluronic Viscosupplementation Market:
- By product, three injection knee hyaluronic acid injection accounts for US$ 1.14 Billion in 2022 owing to the benefits provided in knee osteoarthritis pain.
- By indication, knee osteoarthritis accounted for US$ 2.0 Billion in 2022. Knee osteoarthritis (OA) is a prominent joint disease affecting the quality of life and socioeconomic impact, causing job losses. It affects more than 40% of adults globally and leads to poor or fair health, affecting non-institutionalized adults.
- By molecular weight, high molecular weight hyaluronic viscosupplementation contributed around US$ 1.6 Billion in 2022. Due to the high polymer chain, it easily enters the tissue and has better activity anti-inflammatory activity than low molecular weight hyaluronate.
- By body part, Knee held more than 85.0% of global market share in 2022. As knees are most commonly affected by the osteoarthritis-like condition as one grows older, viscosupplementation in knee osteoarthritis treatments may offer cost-effectiveness and delay total arthroplasty.
- Hospitals and ambulatory surgical centers together held more than 55.0% of the global market share in 2022. This can be ascribed to the fact that the prominent of the world's population suffers from diseases and obesity, which can be adequately identified in these settings with qualified assistance.
- By region, North America held the dominant share of the world in 2022. The U.S. leads in this region with a high prevalence of osteoarthritis and a high requirement of viscosupplementation therapy.
“The rising cases of osteoarthritis and increase in the adoption rate of viscosupplementation treatment contribute to its higher demand and global expansion.” says an analyst of Future Market Insights.
Market Competition of Hyaluronic Viscosupplementation Market:
The hyaluronic viscosupplementation market is highly competitive, with key players including Anika Therapeutics and Seikagaku. These companies are constantly participating in conferences, award competitions with their products, and launching new products to gain a larger market share, with a focus on affordability, convenience, and effectiveness.
- In July 2022, Anika Therapeutics wins ACE Award for Tactoset, a biocompatible, easily injectable, and interdigitating bone graft substitute in Sports Medicine, enhancing hardware augmentation.
- In August 2021, Seikagaku launches HyLink® for knee osteoarthritis treatment in Taiwan.
If You Have Any Further Questions Or Need More Detailed Insights Into The Hyaluronic Viscosupplementation Market And Its Major Players, Speak Directly With Our Research Expert! https://www.futuremarketinsights.com/ask-question/rep-gb-17713
Major Key Players of the Hyaluronic Viscosupplementation Market:
- Anika Therapeutics Inc.
- Zimmer Biomet
- Sanofi S.A.
- LG Chem
- Chugai Pharmaceutical Co., Ltd.
- Meiji Seika Pharma co. ltd
- Ferring B.V.
- Hanmi Pharm.Co., Ltd.
- Anika Therapeutics, Inc.
- Fidia Farmaceutici s.p.a.
- Bioventus LLC
- OrthogenRx
- Seikagaku Corporation
- Bioiberica S.A.U.
- APTISSEN
- Hangzhou Singclean Medical Products Co., Ltd
- Maxigen Biotech Inc.
- TRB Chemedica International SA
- Yuria-Pharm LLC
- Haohai Biological Technology
- Chroma Pharma
Hyaluronic Viscosupplementation Market: Comprehensive Report Coverage:
Future Market Insights offers a unique perspective and actionable insights on the hyaluronic viscosupplementation in its latest study, presenting a historical demand assessment of 2012 – 2022 and projections for 2023 – 2033. The global hyaluronic viscosupplementation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader
The analysis is based on the product (single injection, three injections, five injections, and next-generation (steroid combination)), body parts (knee, hip, shoulder, small joints, and others), molecular weight (high molecular weight, medium molecular weight, low molecular weight), indication (knee osteoarthritis, tendinopathies, shoulder arthritis, hip osteoarthritis, frozen shoulder, ligament injury, post-arthroscopy, and others) end user (hospitals, ambulatory surgical centers, orthopedic clinics, retail pharmacies, and online sales), across seven key regions around the world.
Our Report Is Designed To Assist You In Making Well-Informed Business Decisions And Staying Ahead In The Competitive Landscape. Purchase Now To Access A Valuable Opportunity To Leverage These Insights For Your Strategic Planning And Growth Initiatives! https://www.futuremarketinsights.com/checkout/17713
Key Market Segments Covered in the Hyaluronic Viscosupplementation Industry Research
By Product:
- Single Injection Knee Hyaluronic Acid Injections
- Three Injection Knee Hyaluronic Acid Injections
- Five Injection Knee Hyaluronic Acid Injections
- Next Generation (Steroid Combination)
By Body Parts:
- Knee
- Hip
- Shoulder
- Small Joints
- Others
By Molecular Weight:
- High Molecular Weight
- Medium Molecular Weight
- Low Molecular Weight
By Indication:
- Knee Osteoarthritis
- Tendinopathies
- Shoulder Arthritis
- Hip Osteoarthritis
- Frozen Shoulder
- Ligament Injury
- Post-Arthroscopy
- Others
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Orthopedic Clinics
- Retail Pharmacies
- Online Sales
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Whether You Need An In-Depth Analysis Of A Particular Market Segment, Customized Data Sets, Or A Combination Of Multiple Research Parameters, We Are Here To Assist You! https://www.futuremarketinsights.com/customization-available/rep-gb-17713
Have a Look at Related Research Reports in the Healthcare Domain:
Europe Viscosupplementation Market Size: Rising prevalence of knee osteoarthritis is fuelling demand for effective treatment therapies. Hyaluronic acid-based intra-articular injections have proved to be one of the most preferred choices of treatment for symptomatic knee osteoarthritis.
Russia Viscosupplementation Market Share: The single injection viscosupplementation segment in the Russia viscosupplementation market is expected to expand at the fastest and highest CAGR of 6.0% over the forecast period
Knee Replacement Market Growth: The knee replacement market is anticipated to register a CAGR of 6% during the forecast period, up from US$ 8.27 Bn in 2021 to reach a valuation of US$ 15.7 Bn by 2032.
Knee Walker Market Trend: Growing incidences of knee injuries arising from sports accidents, automobile accidents, and diseases and deficiencies from improper diets and lifestyles are anticipated to propel the knee walker market in the near future.
Knee Arthrodesis Implant Market Forecast: Knee arthrodesis is one of the surgical treatment options used for patients with damaged and painful knees due to failed knee arthroplasty, posttraumatic arthritis, periarticular tumor, and chronic sepsis. Knee arthrodesis is considered as the last option for to damage knee management.
Knee Reconstruction Devices Market Analysis: The global knee reconstruction devices market is expected to reach a market valuation of US$ 8.28 Billion by 2022, accelerating with a moderate CAGR of 4.3% from 2022 to 2032.
Knee Hyaluronic Acid Injections Market Outlook: The knee hyaluronic acid injections market revenue totaled US$ 2.09 billion in 2023, according to the latest insights by the Future Market Insights survey. The overall sales of knee hyaluronic acid injections are expected to reach US$ 3.40 billion, with growth at a CAGR of 5% by 2033.
Hyaluronic Acid Products Market Sales: The global hyaluronic acid products market is expected to attain a valuation of US$ 3,343.5 million in 2023 and is projected to reach US$ 6,838.2 million by 2033, rising at a CAGR of 7.4% during the forecast period.
Non-Hyaluronic Acid Dermal Filler Market Volume: The global non-hyaluronic acid dermal filler market size is expected to reach US$ 520.4 Million by 2032. As per FMI Analysts, the global non-hyaluronic acid dermal filler market is estimated to be valued at US$ 392.7 Million in 2022 and is projected to increase at a CAGR of 2.6% from 2022 to 2032.
Hyaluronic Acid Personal Care Products Market Application: The global hyaluronic acid personal care products market is estimated to reach US$ 7.36 billion by 2033, up from US$ 3.26 billion in 2023. The market is likely to expand at a CAGR of 8.5%.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: sales@futuremarketinsights.com
